MedPath

Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)

Not Applicable
Not yet recruiting
Conditions
Pilonidal Sinus
Pilonidal Sinus Without Abscess
Pilonidal Sinus of Natal Cleft
Pilonidal Disease of Natal Cleft
Pilonidal Disease
Interventions
Procedure: Pit-picking surgery with Sinus Laser assisted Closure
Procedure: Pit-picking surgery
Registration Number
NCT06140199
Lead Sponsor
dr. IJM Han-Geurts
Brief Summary

The goal of this randomized clinical trial is to establish the efficacy of 'pit picking with laser therapy' versus 'pit picking alone' on both short and long-term outcomes in patients of 12 years and older with primary pilonidal sinus disease.

The main questions it aims to answer are:

* The overall success rate of treatment which is defined as: closure of all pits at 12 months of follow-up.

* Secondary endpoints: succes rat eof treatment during long-term follow-up, wound closure time, pain scores, complication rate, work rehabilitation, time to return to daily activities, quality of life, persisting complaints, patient satisfaction, costs and the need for secondary or revision surgery.

Participants will allocated to pit picking alone or combined with lasertherapy.

The extra burden for participating patients is expected to be minimal to moderate. Participants will have two extra hospital visits in casethey are enrolled in our study: 6 and 12 months after enrolment. Postoperatively the normal scheme of follow up appointments wil be used: 2 and 6 weeks after treatment at the outpatient clinic of the treating surgeon. A telephone appointment with the researcher will be scheduled 4 weeks after treatment. Patients are asked to complete questionnaires at various time points, which will be sentto them by email and will take approximately 5-10 minutes each time. The content includes general and disease specific Quality of Life (QoL) questionnaires. The investigators do not expect any extra adverse reactions or events in respect to participation in the study because both procedures are considered standard of care in the participating clinics. However, because both interventions are surgical procedures a small percentage of adverse events or postoperative complications can be expected.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
482
Inclusion Criteria
  • All patients aged 12 years and older who present with primary pilonidal sinus disease; Type 1b and 3 of the Dutch staging system
  • Obtained written informed consent by the patient and/or legal representative/parent
  • Sufficient understanding of the Dutch written language (reading and writing)
  • Eligible for questionnaires sent by e-mail
Exclusion Criteria
  • Asymptomatic (Type 1a), recurrent (Type 4; except those patients who only have had drainage of their abscess and no other surgical treatment), or chronic wounds (hypergranulating) after PSD surgery (Type 5) of the Dutch staging system
  • Patients with known underlying or concomitant medical conditions that may interfere with normal wound healing (e.g. systemic skin and connective tissue diseases, any kind of congenital defect of metabolism including insulin-dependent diabetes mellitus, Cushing syndrome or disease, scurvy, chronic hypothyroidism, congenital or acquired immunosuppressive condition, chronic renal failure, or chronic hepatic dysfunction (Child-Pugh class B or C), severe malnutrition, or other concomitant illness which, in the opinion of the investigator, has the potential to significantly delay wound healing)
  • Severe drug abuse (and therefore protocol deviation can be expected)
  • Patients expected not to comply with the study protocol (including patients with severe cognitive dysfunction/impairment and severe psychiatric disorders)
  • Patients with insufficient knowledge of the Dutch written language who are thus unable to answer the questionnaires
  • Patients that are unable or not willing to give full informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pit-picking surgery with Sinus Laser assisted ClosurePit-picking surgery with Sinus Laser assisted Closure-
Pit-picking surgeryPit-picking surgery-
Primary Outcome Measures
NameTimeMethod
Succes rate of treatment1 year

Success rate of treatment, defined as closure of all pits at 1 year follow-up. Closure of the pits will be assessed by the treating surgeon by means of an extensive physical examination.

Secondary Outcome Measures
NameTimeMethod
Wound healing and complications1 year

Wound and complications

Success rate of treatment at long-term follow-up3-5 years

Success rate of treatment at 3 and 5 years follow up

Pain score6 weeks

Pain scores in the period after surgery (VAS). VAS score scale: 0-10, higher score meaning a worse outcome.

Work rehabilation6 weeks

Work rehabilitation; number of days

Recurrence rate5 years

Recurrence rate at 1, 3 and 5 years of follow-up

Need for secondary or revision surgery5 years

Need for seondary or revision surgery for pilonidal disease

Return to daily activities6 weeks

Time until return to daily activities; number of days

Patient reported outcome measures5 years

PROMs, defined as persisting complaints: itching, wound fluid leakage, blood loss, pus, pain, social burden (shame/embarrassment). PROMs will be scored on a scale: 1-5, with a higher score meaning a worse outcome.

Patient satisfaction5 years

Patient satisfaction with treatment (scored on a likert scale 0-10, with a higher score meaning a better outcome)

Quality adjusted life years (QALYs)5 years

Quality of life after treatment (Eq-5d-5l; will be converted to Quality adjusted life years (QALYs; range 0-1, with 1 the highest score and the better outcome)

Absence of symptoms1 year

Absence of symptoms at 1-yars follow-up: participants will be asked a dichotomous question during their 1-year follow-up appointment. At that moment, do they feel their symptoms from pilonidal sinus disease are: A) cured or improved when compared with before treatment? or B) unchanged or worse when compared with before treatment?

© Copyright 2025. All Rights Reserved by MedPath